Parkinson's Disease Clinical Trial
Enrolling Now

Clinics: Greater Manchester EPU

Therapy Area: Parkinson’s Disease

Gender and Age: Males & Females aged 40 – 75

Reimbursement: Between £1,240 and £1345 plus travel or transport.

About The Research...

We are currently conducting a clinical trial for people with Parkinson’s disease.

The study will run at our Greater Manchester clinic and will require 3 outpatient visits, 2 single night residential visits (stopovers) and 5 MRI brain scans over 5 to 6 weeks.

Parkinson’s disease is the second most common neurodegenerative disease, affecting approximately 1–2% of individuals aged 65 or over. Parkinson’s disease is a condition in which cells that produce dopamine, a chemical responsible for movement in the brain, stop working properly and those cells are lost over time. Symptoms of Parkinson’s disease start to appear when the brain can’t make enough dopamine to control movement properly. Symptoms often start slowly and progress over time.

The purpose of this study is to individually test two study drugs that are being developed for the treatment of the condition. All eligible participants will receive either one of the two study drugs during the trial.

A full description of the study will be given to you before you decide to take part, both over the phone and during an appointment at the MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.

Reimbursement: Between £1,240 and £1345 plus travel or transport.

Criteria

* Key Inclusion Criteria:

  • Age 40 – 75
  • Diagnosis of Parkinson’s disease

* Key Exclusion Criteria:

  • Unable to attend study visits or comply with study restrictions
  • Unable to undergo an MRI scan

Other eligibility criteria will apply. Please contact MAC for more information.

Any other information

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.

Key Inclusion Criteria

  •  

Key Exclusion Criteria

  •  

MAC Clinical Research is conducting a trial to evaluate a potential new treatment for Parkinson’s Disease.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • (You can enter any supporting information here)
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email